Answers are grounded in this paper and cite their sources.
Drug Administration) for the treatment of patients with schizophrenia and depressive episodes associated with bipolar disorder in 2019. Literature review. The review includes up-to-date publications concerning the efficacy of lumateperone in the treatment of psychiatric disorders -schizophrenia, bipolar disorder, but also insomnia, and dementia. The pharmacokinetic and pharmacodynamic characteristics of lumateperone and its precise mechanism of action were presented. The adverse reactions and possible drug interactions were likewise discussed. Conclusions. Lumateperone is a medication with an interesting mechanism of action, which is unique compared to other antipsychotic drugs. The analysis of clinical trials suggests that lumateperone is an effective and safe medication for the treatment of schizophrenia, as well as bipolar affective disorder. There are high hopes for the use of lumateperone in the treatment of insomnia and dementia.
No takes yet. Share an insight, caveat, or question.
Kaczmarek et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: